Published in Health Business Week, December 15th, 2006
Nephros reported a net loss attributable to common stockholders in the third quarter of 2006 of $1,905,528, or $0.15 loss per basic and diluted share, compared to a loss of $1,747,882, or $0.14 loss per basic and diluted share, in the year-earlier period. The average number of basic and diluted common shares for the quarter was 12,317,992, compared to 12,307,089 for the quarter ended September 30, 2005.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week